Understanding Atopic Dermatitis: Pathophysiology and Management Strategies
Biomolecules · 24.10.2025 · 15 (11) · 1500
DOI: 10.3390/biom15111500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 24.10.2025. Verfasst von Heng Chai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Provincial Key R&D Program Project.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by itching, redness, and dryness, significantly impacting the quality of life of affected individuals. With a rising prevalence across diverse demographics, understanding AD is crucial due to its systemic nature and association with comorbidities such as asthma and allergic rhinitis, as well as its psychosocial implications. The pathophysiology of AD involves a complex interplay of genetic predispositions and environmental triggers, leading to dysbiosis and increased susceptibility to superinfection. Clinically, AD manifests variably across age groups, with distinct presentations in pediatric and adult populations. Diagnosis is primarily based on clinical assessment criteria, supplemented by differential diagnoses and, when necessary, skin tests for allergies. Current management strategies encompass topical therapies, including moisturizers, corticosteroids, and calcineurin inhibitors, alongside systemic treatments such as antihistamines, immunosuppressants, and biologics. Lifestyle modifications, including trigger avoidance and effective skin care routines, are essential components of comprehensive care. Emerging novel therapies targeting specific biomarkers are currently under investigation in clinical trials, offering promising avenues for more effective management. However, challenges remain in optimizing treatment protocols and addressing the multifaceted nature of AD. In conclusion, this review highlights the need for continued research and awareness regarding atopic dermatitis. A multidisciplinary approach to management is essential to enhance patient outcomes and address the complexities of this prevalent and impactful condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
- Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
- Guangdong-Hong Kong-Macau Joint Laboratory for Pharmacodynamic Constituents of TCM and New Drugs Research, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
ORCID-Profile: Wing Sum Siu, Hui Ma
Förderung
- Heilongjiang Provincial Key R&D Program Project
Zitieren
APA
Chai, H., Siu, W. S., Ma, H., & Li, Y. (2025). Understanding Atopic Dermatitis: Pathophysiology and Management Strategies. Biomolecules, 15(11), 1500. https://doi.org/10.3390/biom15111500
Vancouver
Chai H, Siu WS, Ma H, Li Y. Understanding Atopic Dermatitis: Pathophysiology and Management Strategies. Biomolecules. 2025;15(11):1500. doi:10.3390/biom15111500
BibTeX
@article{Chai2025,
author = {Chai, Heng and Siu, Wing Sum and Ma, Hui and Li, Yuzhen},
title = {Understanding Atopic Dermatitis: Pathophysiology and Management Strategies},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {11},
pages = {1500},
doi = {10.3390/biom15111500}
}
EUVIMED